• Gene Expression of Protein Tyrosine Phosphatase 1B and Endoplasmic Reticulum Stress During Septic Shock

    Protein Tyrosine Phosphatase 1B (PTP1B) and endoplasmic reticulum stress (ERS) are involved in the septic inflammatory response. Their inhibition is associated with improved survival in murine models of sepsis. In a recent publication in Frontiers in Medicine Dr Clavier et al showed in a study of 40 patients with septic shock that gene expression variation in blood samples of PTPN1 and ATF6  partly correlate with the evolution of septic organ failure and with markers of endothelial dysfunction. The recent identification of PTP1B as a novel negative regulator of host defense against sepsis may have potential therapeutic implications. However, further studies are needed to better understand PTP1B and ERS implication during sepsis in humans.

     

    Read more

  • Thesis defense 2019

    logo presThis autumn four PhD students have defended their thesis in our laboratory:

    - Mouad Hamzaoui
    - Bérénice Colleville
    - Frédéric Roca
    - Matthieu Leuillier

     

     

    20191126 Mouad

    Dr Mouad Hamzaoui (Dir. Dominique Guerrot)

    "Rôle de la dysfonction endothéliale dans les complications cardiovasculaires et rénales de la polykystose rénale autosomique dominante: intérêt d’une modulation pharmacologique par agonistes dopaminergiques"

    20191209 Berenice

    Dr Bérénice Colleville (Dir. Eric Durand)

    "Identification de nouvelles cibles thérapeutiques dans le rétrécissement aortique"

     20191212 Fred Roca

    Dr Frédéric Roca (Dir Robinson Joannides)

    "Évaluation in vivo de la viscosité pariétale des artères de conductance : impact du vieillissement, de la dysfonction endothéliale et de la réduction pharmacologique de la fréquence cardiaque"

    20191216 Matthieu

    Dr Matthieu Leuillier (Dir. Jeremy Bellien)

    "Rôle de l'activité phosphatase de l'époxyde hydrolase soluble dans la régulation de l'homéostasie métabolique et cardiovasculaire"

    Read more

  • Arterial viscosity increase in essential hypertension

    ArFigure thumbnail fx1terial wall viscosity is regulated by endothelium-derived NO and epoxyeicosatrienoic acids (EETs) under baseline physiological conditions. Whether these factors regulate arterial viscosity during blood flow increase and whether this mechanism is affected in patients with essential hypertensive have remained unknown.

    In a recent publication in Atherosclerosis Dr Roca et al showed in a study of 18 untreated hypertensive patients and 14 normotensive controls that baseline arterial viscosity was increased in hypertensive patients. Whereas pharmacological inhibition of NO and/or EETs increased arterial viscosity in response to flow-mediated dilatation, these inhibitors did not modify the arterial viscosity in hypertensive patients.

    Thus, the release of NO and EETs maintains a stable arterial wall viscosity during flow increase and this endothelial adaptive regulation is lost during essential hypertension, which may promote excessive viscous energy dissipation and cardiovascular uncoupling. Restoration of EETs availability with inhibitors of soluble epoxide hydrolase could thus constitute a promising pharmacological approach to restore the endothelial adaptive regulation of AWV.

    Read more

  • Publication in Am J Physiol : PTP1B in cardiovascular aging

    Our publication demonstrating the benefits of PTP1B gene deletion on the cardiovascular consequences of aging published in  Am J Physiol PMID: 29569957

    Read more

Inserm U1096

u1096-2014small

Research performed in Inserm U1096 Unit in Rouen, concerns evaluation of the mechanisms behind and novel treatments of cardiovascular diseases, focusing on vascular protection and improvement of cardiac contractile function. This research is transversal, and performed both in experimental models and in human.

Vascular research: 

Our work mostly concerns the protection of vascular endothelial cells in the context of cardiovascular risk factors or cardiovascular diseases (hypertension, diabetes, myocardial infarction, heart failure etc. ). We also investigate new biotherapy approaches for stimulation of cardiac angiogenesis and lymphangiogenesis.

Cardiac research:

Development and assessment of new treatments of heart failure, as well as the clinical evaluation of percutaneous aortic valve replacement.

INSERM U1096

Endothelium, Valvulopathy
& Heart Failure

Réalisation Internet Bordeaux LOGO internet bordeaux mini

Contact Us

Legal mentions